All News

Society wants the healthcare system to improve the population's overall health while caring for the sick at a lower overall cost. The term of art is providing value-based care. Yet system leaders are stuck with a reimbursement system that still rewards volume through fee-for-service medicine.

For patients with KRAS wild-type untreated colorectal cancer, adding cetuximab or bevacizumab to combination chemotherapy offers equivalent survival, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer in Barcelona

Patients with non-Hodgkin's lymphoma who have received 8 or more CT scans have a 2-fold risk for secondary primary malignancies, new research shows.

A proposed Centers for Medicare & Medicaid Services ruling would make it easier for consumers to automatically re-enroll in their plans from the healthcare insurance exchanges if they liked them.

People with type 1 or 2 diabetes now have a new means of getting their medication, with the U.S. Food and Drug Administration's approval on Friday of the first inhaled medicine for the blood sugar disease.

A CMS rule that exempts drug and medical-device companies from having to disclose indirect payments to physicians for accredited continuing medical education could prompt manufacturers to shift their marketing dollars toward CME and away from direct promotional programs for their products, experts say.

President Barack Obama plans to nominate former Procter & Gamble CEO and West Point graduate Robert McDonald as the next Veterans Affairs secretary.

Caloric restriction in women with the triple negative disease was found to reduce incidence of metastases in a pre-clinical model.

Scientists in Germany have developed a vaccine that they say provides some protection against brain tumors in mice.

Medicaid expansion continues to vary in popularity. Twenty-six states and the District of Columbia plan to expand Medicaid, while 4 are actively considering it and 20 have no plans to do so.

Avastin is the first biologic medicine to receive a CHMP positive opinion for the most difficult to treat form of ovarian cancer.

Providers recently reviewed the cost-effectiveness of accountable care organizations (ACOs). While half of surveyed providers said value-based reimbursement had potential to improve population health management, as well as the patient experience, 80% said it would require more staff, more time, and greater financial investments.

The longer a person took low-dose aspirin, the lower his or her risk for developing pancreatic cancer, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

CMS stated that they seek recommendations about how the ACO program might evolve to "encourage greater care integration and financial accountability."

Adherence is important to improving the health outcomes of patients with diabetes. Health technology and digital tools are just on way providers are encouraging patients to remain consistent with the treatment regimens.

Smart watches, mHealth apps, and Bluetooth scales may just be edging into the social consciousness as a viable way to monitor personal health and manage chronic diseases, but EHR developers have been eyeing these technologies for some time, seeing them as valuable tools in the struggle to engage patients, prevent unnecessary readmissions, reduce costs, and promote long-term health.

Hospital outpatient prices for standard blood tests, cancer screening and other services varied widely and were sharply higher, on average, than prices charged by ambulatory clinics and independent doctors, an analysis of autoworker health-plan spending across 18 cities has found.

Results indicate that nivolumab is likely to prolong survival in advanced melanoma.

Safety concerns over the PARP inhibitor warranted the request for additional data.

Taking a more strategic approach to payer relationships may be the key to surviving new reimbursements models.

Increasingly, pharmacy benefit managers (PBMs) are refusing to purchase high-cost drugs from manufacturers or include them in their formularies - the lists of drugs that a health plan will cover.

Physician groups are lobbying hard to extend an Obamacare provision that requires state Medicaid programs to pay primary-care physicians at higher Medicare rates to improve access for Medicaid patients. But to persuade congressional Republicans to go along, they are downplaying the fact that the pay bump is part of the Patient Protection and Affordable Care Act.

This week, The American Journal of Managed Care is covering CBI's 7th Summit on Managed Care Market Strategies taking place in Philadelphia, PA. The event includes stakeholder perspectives on improving market access and product value propositions in the evolving healthcare landscape. We continue to spotlight session highlights.

Phase II study findings show only marginal positive effects of third-line treatment with afatinib for advanced non-small-cell lung cancer (NSCLC) in patients with wild-type epidermal growth-factor receptor (EGFR) tumour status.

This spring as the feds have been drawing up new rules for the program, a pitched battle has broken out between hospitals and drug manufacturers who say the program, known as 340B, is now bloated and badly regulated.

The FDA staff report questioned the unusually poor performance of the control group used in the study.

The Senate introduced legislation this week that would require Medicare to consider patients' finances when deciding whether to punish a hospital for readmission numbers.

Virginia Gov. Terry McAuliffe vowed Friday to bypass the General Assembly and expand Medicaid eligibility for about 400,000 low-income residents on his own.

I'll say it: I think most states, if not all, will be on the Federal exchange by the end of the decade.

With just two weeks under her belt, Health and Human Services (HHS) Secretary Sylvia Mathews Burwell announced a series of changes that will be made to the federal health insurance marketplace following the enrollment and technological problems that ensued the launch of healthcare.gov earlier this year.